Manufacturing COVID-19 vaccines

The rapid production of safe, effective and consistent vaccines is essential for supporting COVID-19 immunisation programmes in the UK and globally. However, manufacturing vaccines is challenging for various reasons that include the complex processes involved, the specialist knowledge and experience required, and the natural variability of the biological materials and systems used. Urgent demand is leading to manufacturers and governments taking on significant financial risks in order to speed up production. What is the UK Government doing to accelerate vaccine manufacture? How are vaccines made? Why is manufacturing vaccines at large scales so challenging?

Manufacturing COVID-19 vaccines

Brain-computer interfaces

Brain-Computer Interfaces (BCIs) measure brain activity and can be used to control digital devices. The focus of BCI development has been on using the technology to allow patients to control assistive equipment such as wheelchairs or prostheses. Beyond medicine they are under development for applications in entertainment, marketing and defence. This POSTnote looks at the underpinning technology, its applications and the associated ethical and regulatory challenges.

Brain-computer interfaces

Total results (page 1 of 2)